The role of calcium channel blockers and resveratrol in the prevention of paraquat-induced parkinsonism in Drosophila melanogaster: A locomotor analysis

Invertebrate Neuroscience

Volumn 11, Issue 1, 2011, Pages 43-51

  Bagatini, Pamela Brambilla ^a   Saur, Lisiani ^a   Rodrigues, Mariana Freitas ^a   Bernardino, Guilherme Cardoso ^a   Paim, Mariana Fontoura ^a   Coelho, Guilherme Peres ^a   Da Silva, Daniele Vieira ^a   De Oliveira, Raquel Mattos ^a   Schirmer, Helena ^b   Souto, André Arigony ^b   Vianna, Mônica Ryff Moreira Roca ^a   Xavier, Léder Leal ^a  

^a Faculdade de Biociencias   (Brazil)

^b UNIVERSIDADE FEEVALE   (Brazil)

Author keywords

Dihydropyridines; Drosophila melanogaster; Paraquat; Parkinson's disease; Resveratrol; Voltage dependent calcium channels

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DOPAMINE; PARAQUAT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DROSOPHILA MELANOGASTER; DRUG EFFECT; METABOLISM; NERVE DEGENERATION; PARKINSONISM; SUBSTANTIA NIGRA;

ANIMALS; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DOPAMINE; DROSOPHILA MELANOGASTER; NERVE DEGENERATION; PARAQUAT; PARKINSONIAN DISORDERS; STILBENES; SUBSTANTIA NIGRA;

EID: 80052493584     PISSN: 13542516     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10158-011-0116-3     Document Type: Article

References (57)

1. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L (2007) Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev 128:546-552 (Pubitemid 47498522)
2. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
3. Bayersdorfer F, Voigt A, Schneuwly S, Botella JA (2010) Dopaminedependent neurodegeneration in Drosophila models of familial and sporadic Parkinson's disease. Neurobiol Dis 40:113-119
4. Belgacem YH, Martin JR (2002) Neuroendocrine control of a sexually dimorphic behavior by a few neurons of the pars intercerebralis in Drosophila. Proc Natl Acad Sci USA 99:15154-15158
5. Botella JA, Bayersdorfer F, Gmeiner F, Schneuwly S (2009) Modelling Parkinson's disease in Drosophila. Neuromolecular Med 11:268-280
6. Chan CS, Guzman JN, Ilijic E, Mercer JN, Rick RC, Tkatch T, Meredith GE, Surmeier DJ (2007) 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447:1081-1089
7. Chan CS, Gertler TS, Surmeier DJ (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32:249-256
8. Chaudhuri A, Bowling K, Funderburk C, Lawal H, Inamdar A, Wang Z, O'Donnel JM (2007) Interaction of genetic and environmental factors in a Drosophila Parkinsonism model. J Neurosci 27:2457-2467 (Pubitemid 46393605)
9. Chinta SJ, Poksay KS, Kaundinya G, Hart M, Bredesen DE, Andersen JK, Rao RV (2009) Endoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrol. J Mol Neurosci 39:157-168
10. Chuang CS, Su HL, Cheng FC, Hsu SH, Chuang CF, Liu CS (2010) Quantitative evaluation of motor function before and after engraftment of dopaminergic neurons in a rat model of Parkinson's disease. J Biomed Sci 17:9
11. Clark J, Milakovic M, Cull A, Klose MK, Mercier AJ (2008) Evidence for postsynaptic modulation of muscle contraction by a Drosophila neuropeptide. Peptides 29:1140-1149
12. Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. II. Patterns of loss of dopaminecontaining neurons in Parkinson's disease. Brain 122:1437-1448 (Pubitemid 29374122)
13. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909 (Pubitemid 37130207)
14. Decamp E, Schneider JS (2009) Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model. Brain Res 1262:109-114
15. Dinis-Oliveira RJ, Remião F, Carmo H, Duarte JA, Sánchez NA, Bastos ML, Carvalho F (2006) Paraquat exposure as an etiological factor of Parkinson's disease. Neurotoxicology 27:1110-1122 (Pubitemid 44838957)
16. Farkas E, De Jong GI, Apró E, Keuker JIH, Luiten PGM (2001) Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain. Neurobiol Aging 22:299-309 (Pubitemid 32162979)
17. Girardot F, Monnier V, Tricoire H (2004) Genome wide analysis of common and specific stress responses in adult Drosophila melanogaster. BMC Genomics 5:74
18. Halliday GM, McRitchie DA, Cartwright HR, Pamphlett RS, Hely MA, Morris JGL (1996) Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J Clin Neurosci 3:52-60 (Pubitemid 126658461)
19. Hart C, Kisro NA, Robinson SL, Ksir C (1996) Effects of the calcium channel blocker nimodipine on nicotine-induced locomotion in rats. Psychopharmacology (Berl) 128:359-361 (Pubitemid 26417677)
20. Hu LF, Lu M, Tiong CX, Dawe GS, Hu G, Bian JS (2010) Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 9:135-146
21. Ito K, Awasaki T (2008) Clonal unit architecture of the adult fly brain. In: Technau GM (ed) Brain development in Drosophila melanogaster, Springer series: advances in experimental medicine and in experimental biology. Landes Bioscience and Springer Science ? Business Media, New York, pp 137-158
22. Jimenez-Del-Rio M, Daza-Restrepo A, Velez-Pardo C (2008) The cannabinoid CP55, 940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease. Neurosci Res 61:404-411
23. Jimenez-Del-Rio M, Guzman-Martinez C, Velez-Pardo C (2010) The effects of polyphenols on survival and locomotor activity in Drosophila melanogaster exposed to iron and paraquat. Neurochem Res 35:227-238
24. Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K, Islam F (2010) Resveratrol attenuates 6-hydroxydopamine- induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res 1328:139-151
25. King GF (2007) Modulation of insect Cav channels by peptidic spider toxins. Toxicon 49:513-530 (Pubitemid 46341389)
26. Kupsch A, Gerlach M, Pupeter SC, Sautter J, Dirr A, Arnold G, Opitz W, Przuntek H, Riederer P, Oertel WH (1995) Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice. Neuroreport 6:621-625
27. Kupsch A, Sautter J, Schwarz J, Riederer P, Gerlach M, Oertel WH (1996) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level. Brain Res 741:185-196 (Pubitemid 26426315)
28. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109-1122 (Pubitemid 44894520)
29. Lee H-S, Lee K-S, Yu K, Hong S-Y (2008) Expression of genes related to parkinson's disease after paraquat treatment in Drosophila melanogaster. Pestic Biochem Physiol 92:19-23
30. Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA (2010) L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia. J Neurochem 112:1465-1476
31. Long J, Gao H, Sun L, Liu J, Zhao-Wilson X (2009) Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. Rejuvenation Res 12:321-331
32. Marambaud P, Dreses-Werringloer U, Vingtdeux V (2009) Calcium signaling in neurodegeneration. Mol Neurodegener 4:20.
33. Martin JR (2004) A portrait of locomotor behaviour in Drosophila determined by a video-tracking paradigm. Behav Processes 67:207-219
34. Mattson MP (2007) Calcium and neurodegeneration. Aging Cell 6:337-350
35. McCann SJ, LeCouteur DG, Green AC, Brayne C, Johnson AG, Chan D, McManus ME, Pond SM (1998) The epidemiology of Parkinson's disease in an Australian population. Neuroepidemiology 17:310-317 (Pubitemid 28482049)
36. Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ (2008) Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism Relat Disord 14:S112-S115
37. Neckameyer WS, Matsuo H (2008) Distinct neural circuits reflect sex, sexual maturity, and reproductive status in response to stress in Drosophila melanogaster. Neuroscience 156:841-856
38. Nichols CD (2006) Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Pharmacol Ther 112:677-700 (Pubitemid 44573493)
39. Paganini-Hill A (2001) Risk factors for Parkinson's disease: the leisure world cohort study. Neuroepidemiology 20:118-124 (Pubitemid 32453730)
40. Parashar V, Rogina B (2009) dSir2 mediates de increased spontaneous physical activity in flies on calorie restriction. Aging 1:529-541
41. Pendleton RG, Parvez F, Sayed M, Hillman R (2002) Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. J Pharmacol Exp Ther 300:91-96 (Pubitemid 34028513)
42. Pesah Y, Pham T, Burgess H, Middlebrooks B, Verstreken P, Zhou Y, Harding M, Bellen H, Mardon G (2004) Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131:2183-2194 (Pubitemid 38702049)
43. Rodnitzky RL (1999) Can calcium antagonists provide a neuroprotective effect in Parkinson's disease? Drugs 57:845-849 (Pubitemid 29313195)
44. Rylander D, Recchia A, Mela F, Dekundy A, Danysz W, Cenci MA (2009) Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling. J Pharmacol Exp Ther 330:227-235
45. Sansone M, Battaglia M, Pavone F (1995) Enhancement by nifedipine of cholinergic-induced depression of locomotor activity in mice. Funct Neurol 10:163-167 (Pubitemid 26077106)
46. Schapira AHV (2009) Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci 30:41-47
47. Schuster S, Doudnikoff E, Rylander D, Berthet A, Aubert I, Ittrich C, Bloch B, Cenci MA, Surmeier DJ, Hengerer B, Bezard E (2009) Antagonizing L-type Ca2? channel reduces development of abnormal involuntary movement in the rat model of L-3,4- dihydroxyphenylalanine-induced dyskinesia. Biol Psychiatry 65:518-526
48. Souto AA, Carneiro MC, Seferin M, Senna MJH, Conz A, Gobbi K (2001) Determination of trans-resveratrol concentrations in Brazilian red wines by HPLC. J Food Compost Anal 14:441-445 (Pubitemid 33077453)
49. Sulzer D, Schmitz Y (2007) Parkinson's disease: return of an old prime suspect. Neuron 55:8-10 (Pubitemid 46990827)
50. Sun AY, Wang Q, Simonyi A, Sun GY (2008) Botanical phenolics and brain health. Neuromolecular Med 10:259-274
51. Sun AY, Wang Q, Simonyi A, Sun GY (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41:375-383
52. Surmeier DJ (2007) Calcium, ageing, and neuronal vulnerability in Parkinson's disease. Lancet Neurol 6:933-938 (Pubitemid 47405004)
53. Watson WP, Little HJ (2002) Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome. Brain Res 930:111-122 (Pubitemid 34195634)
54. Whitworth AJ, Wes PD, Pallanck LJ (2006) Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discov Today 11:119-126 (Pubitemid 43375962)
55. Worrell JW, Levine RB (2008) Characterization of voltage-dependent Ca2 currents in identified Drosophila motoneurons in situ. J Neurophysiol 100:868-878
56. Xu K, Xu YH, Chen JF, Schwarzschild MA (2010) Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease. Neuroscience 167:475-481
57. Yang H, Baur JA, Chen A, Miller C, Adams JK, Kisielewski A, Howitz KT, Zipkin RE, Sinclair DA (2007) Design and synthesis of compounds that extend yeast replicative lifespan. Aging Cell 6:35-43 (Pubitemid 46140138)